Everi (EVRI) Stock Price, News & Analysis

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Everi in the last year. There are currently 3 hold ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EVRI shares.
View EVRI analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued twelve-month target prices for Everi's stock. Their EVRI share price targets range from $12.00 to $24.00. On average, they expect the company's share price to reach $15.60 in the next year. This suggests a possible upside of 76.8% from the stock's current price.
View analysts price targets for EVRI or view top-rated stocks among Wall Street analysts.

Everi's stock was trading at $11.27 on January 1st, 2024. Since then, EVRI shares have decreased by 21.7% and is now trading at $8.8250.
View the best growth stocks for 2024 here.

Everi saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 4,450,000 shares, a decrease of 14.1% from the March 15th total of 5,180,000 shares. Based on an average daily trading volume, of 1,100,000 shares, the days-to-cover ratio is currently 4.0 days. Approximately 5.5% of the shares of the company are sold short.
View Everi's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our EVRI earnings forecast.

Everi will be holding an earnings conference call on Wednesday, May 8th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13745956".

Everi Holdings Inc. (NYSE:EVRI) announced its quarterly earnings data on Thursday, February, 29th. The credit services provider reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.21 by $0.19. The credit services provider earned $192 million during the quarter, compared to analysts' expectations of $200.99 million. Everi had a net margin of 10.40% and a trailing twelve-month return on equity of 42.93%. Everi's revenue was down 6.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.28 earnings per share.

ETFs with the largest weight of Everi (NYSE:EVRI) stock in their portfolio include B.A.D. Etf (BAD), Pacer BlueStar Digital Entertainment ETF (ODDS) and Roundhill Acquirers Deep Value ETF (DEEP).Roundhill Sports Betting & iGaming ETF (BETZ).

75 employees have rated Everi Chief Executive Officer Michael D. Rumbolz on Glassdoor.com. Michael D. Rumbolz has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Everi investors own include Inovio Pharmaceuticals (INO), Matinas BioPharma (MTNB), Organigram (OGI), New Residential Investment (NRZ), General Electric (GE), ADMA Biologics (ADMA), Dynavax Technologies (DVAX), Chesapeake Energy (CHKAQ), Sorrento Therapeutics (SRNE) and Nokia Oyj (NOK).

Everi's stock is owned by a number of institutional and retail investors. Top institutional shareholders include ARGA Investment Management LP (0.08%) and Insight Folios Inc (0.02%). Insiders that own company stock include Darren Simmons, David Lucchese, Dean A Ehrlich, Eileen F Raney, Geoffrey P Judge, Linster W Fox, Mark F Labay, Michael D Rumbolz, Randy L Taylor, Ronald V Congemi, Secil Tabli Watson and Todd A Valli.
View institutional ownership trends.

Shares of EVRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.